Millar Kerri-Ann 4
4 · Cue Biopharma, Inc. · Filed Aug 23, 2022
Insider Transaction Report
Form 4
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2022-08-22$3.05/sh−2,828$8,625→ 14,311 total - Exercise/Conversion
Common Stock
2022-08-21+6,667→ 17,139 total - Exercise/Conversion
Restricted Stock Units
2022-08-21−6,667→ 0 total→ Common Stock (6,667 underlying)
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020.